Dr. Dilara Bahceci, PhD, is a neuropharmacologist focused on the clinical development of psychoactive treatments, including psychedelics, ketamine, MDMA, and cannabinoids. Earning her PhD in medicinal cannabis for childhood epilepsy, Dr. Bahceci has amassed a decade of research and drug development experience across academia, the private sector, and startups. She has played a pivotal role in transforming psychoactive drugs into recognized medical treatments. Currently, she is a Research Fellow advancing 'breakthrough therapies' to create effective and accessible mental health treatments at the George Institute for Global Health. Additionally, Dr. Bahceci specializes in scientific communication, serving as the Head of Communications at Psylo, a biotech company at the forefront of developing novel psychedelic-inspired therapeutics. She also authors a popular newsletter on psychedelic science.